Use of Direct Oral Anticoagulants (DOACs) in Patients With Ph-negative Myeloproliferative Neoplasms
Clinical trial NCT04192916 · COMPLETED
Trial details
- NCT number
- NCT04192916
- Sponsor
- FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2019-09-01
- Primary completion
- 2020-03-31
- Enrollment
- 442
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.